615. Deputy Róisín Shortall asked the Minister for Health further to Parliamentary Question No. 771 of 7 November 2017, the status of the PRAC's review of valproate; the response of the HPRA to the outcome of this review; the steps it will take to increase awareness of the potential side effects of this drug in pregnant women; the multidisciplinary team services that are available to children born with FACS; and if he will make a statement on the matter. [24443/18]

Summary

615. Deputy Róisín Shortall asked the Minister for Health further to Parliamentary Question No. 771 of 7 November 2017, the status of the PRAC's review of valproate; the response of the HPRA to the outcome of this review; the steps it will take to increase awareness of the potential side effects of this drug in pregnant women; the multidisciplinary team services that are available to children born with FACS; and if he will make a statement on the matter. [24443/18]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products Regulation

  xml · EN · 12 June 2018

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.